Acne Control Cleanser

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

The product is to be used up to twice daily. Prior to application, the user should wet the face thoroughly. A sufficient amount of the product should be applied to the hands, followed by the addition of water to create a lather. The lather should then be gently massaged onto the face. It is important to rinse the face well after massaging to ensure complete removal of the product.

Contraindications

Use of this product is contraindicated in individuals with a history of eye contact. In the event of contact with the eyes, it is imperative to flush thoroughly with water to mitigate potential irritation or injury. No other contraindications have been specified.

Warnings and Precautions

For external use only. This product is not intended for ingestion. In the event of accidental swallowing, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should advise patients to avoid contact with the eyes. Should contact occur, it is essential to flush the eyes thoroughly with water to mitigate any potential irritation or injury.

No specific laboratory tests have been identified for monitoring during the use of this product. However, vigilance in observing any adverse reactions or complications is recommended.

In case of ingestion, prompt medical help is crucial. Patients should be instructed to act swiftly and seek emergency medical assistance or contact a Poison Control Center immediately.

Side Effects

For external use only. No specific adverse reactions have been identified in clinical trials or postmarketing experiences.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Acne Control Cleanser (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The safety of this product during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to the potential risk to the fetus, including the risk of teratogenic effects associated with its use. Pregnant patients should avoid using this product unless directed by a healthcare professional. Dosage modifications may be necessary for pregnant individuals; therefore, consultation with a healthcare provider is recommended to ensure appropriate management and minimize risks to fetal outcomes.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals may consider the use of this medication in lactating mothers without specific concerns related to breastfeeding. However, it is always advisable to monitor breastfed infants for any potential adverse effects when the mother is taking any medication.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while specific overdosage data is not available, healthcare professionals should exercise caution, remain observant for potential overdose symptoms, and implement appropriate management strategies as needed.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the extracted data.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the medication is swallowed. It is crucial for patients to understand the importance of prompt action in such situations.

Patients should be informed to avoid contact with their eyes. In the event of accidental eye contact, they should flush the eyes thoroughly with water to minimize potential irritation.

Additionally, healthcare providers should counsel patients about the risk of skin irritation and dryness associated with the use of this medication, particularly if they are using another topical acne treatment concurrently. It is recommended that patients use only one topical acne medication at a time to reduce the likelihood of irritation.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light to prevent degradation. After opening, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The medication is administered topically and may be used up to twice daily. Clinicians should advise patients that it is for external use only and to avoid simultaneous use with other topical acne medications, as this may increase the likelihood of skin irritation and dryness. In the event of irritation, patients should limit their use to one topical acne treatment at a time.

Patients should be counseled to keep the medication out of reach of children. If ingested, they should seek medical assistance or contact a Poison Control Center immediately. Additionally, patients should avoid contact with the eyes; if contact occurs, they should flush the eyes thoroughly with water.

Drug Information (PDF)

This file contains official product information for Acne Control Cleanser, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)